Reaction Details |
| Report a problem with these data |
Target | Beta-glucuronidase |
---|
Ligand | BDBM163643 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Cell-Based Assay |
---|
IC50 | 721.7±31.3 nM |
---|
Citation | Redinbo, MR Selective β-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents US Patent US9334288 Publication Date 5/10/2016 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Beta-glucuronidase |
---|
Name: | Beta-glucuronidase |
Synonyms: | β-Glucuronidase | BGLR_HUMAN | Beta-G1 | Beta-glucuronidase | GUSB | beta-Glucuronidase (β-glucuronidase) |
Type: | Protein |
Mol. Mass.: | 74736.05 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 651 |
Sequence: | MARGSAVAWAALGPLLWGCALGLQGGMLYPQESPSRECKELDGLWSFRADFSDNRRRGFE
EQWYRRPLWESGPTVDMPVPSSFNDISQDWRLRHFVGWVWYEREVILPERWTQDLRTRVV
LRIGSAHSYAIVWVNGVDTLEHEGGYLPFEADISNLVQVGPLPSRLRITIAINNTLTPTT
LPPGTIQYLTDTSKYPKGYFVQNTYFDFFNYAGLQRSVLLYTTPTTYIDDITVTTSVEQD
SGLVNYQISVKGSNLFKLEVRLLDAENKVVANGTGTQGQLKVPGVSLWWPYLMHERPAYL
YSLEVQLTAQTSLGPVSDFYTLPVGIRTVAVTKSQFLINGKPFYFHGVNKHEDADIRGKG
FDWPLLVKDFNLLRWLGANAFRTSHYPYAEEVMQMCDRYGIVVIDECPGVGLALPQFFNN
VSLHHHMQVMEEVVRRDKNHPAVVMWSVANEPASHLESAGYYLKMVIAHTKSLDPSRPVT
FVSNSNYAADKGAPYVDVICLNSYYSWYHDYGHLELIQLQLATQFENWYKKYQKPIIQSE
YGAETIAGFHQDPPLMFTEEYQKSLLEQYHLGLDQKRRKYVVGELIWNFADFMTEQSPTR
VLGNKKGIFTRQRQPKSAAFLLRERYWKIANETRYPHSVAKSQCLENSLFT
|
|
|
BDBM163643 |
---|
n/a |
---|
Name | BDBM163643 |
Synonyms: | 2[4(2H1,3benzodioxol5ylmethyl)piperazin1yl]N(2,5dimethoxycyclohexyl)acetamide (Inh 8) | US9334288, 8 |
Type | Small organic molecule |
Emp. Form. | C22H33N3O5 |
Mol. Mass. | 419.5145 |
SMILES | COC1CCC(OC)C(C1)NC(=O)CN1CCN(Cc2ccc3OCOc3c2)CC1 |
Structure |
|